Literature summary for 3.4.14.5 extracted from

Balas, B.; Baig, M.R.; Watson, C.; Dunning, B.E.; Ligueros-Saylan, M.; Wang, Y.; He, Y.L.; Darland, C.; Holst, J.J.; Deacon, C.F.; Cusi, K.; Mari, A.; Foley, J.E.; DeFronzo, R.A.
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients (2007), J. Clin. Endocrinol. Metab., 92, 1249-1255.

Search for more literature for 3.4.14.5

Application

Application	Comment	Organism
medicine	the dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients	Homo sapiens

Inhibitors

Inhibitors	Comment	Organism	Structure
vildagliptin	suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Synonyms

Synonyms	Comment	Organism
dipeptidyl peptidase IV	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)